The incidence and risk factors of extrapulmonary manifestations in Mycoplasma pneumoniae pneumonia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Mycoplasma pneumoniae pneumonia (MP) is a major cause of community-acquired pneumonia (CAP) in children and is associated with extrapulmonary manifestations (EPM). The incidence and risk factors for EPM in children are unknown. Methods: This was a retrospective study involving 65,243 pediatric patients with CAP between 2010 and 2015 at 23 nationwide hospitals in South Korea. Medical records were reviewed to collect information regarding the clinical characteristics, radiological results, and laboratory findings. Logistic regression with multivariate analysis was performed to evaluate the risk factors associated with EPM in MP. Results: The incidence of EPM was 23.9%, including elevation of liver enzymes (18.1%), mucocutaneous manifestations (4.4%), proteinuria (4.1%), cardiovascular and neurological manifestations (0.4%), hematologic manifestations (0.2%), and arthritis (0.2%). Statistical analysis showed that mucocutaneous manifestations significantly increased with elevated alanine aminotransferase (adjusted odds ratio [aOR], 3.623; 95% confidence interval [CI], 1.933-6.790) and atopic sensitization (aOR, 2.973; 95% CI, 1.615–5.475) and decreased with respiratory virus coinfection (aOR, 0.273; 95% CI, 0.084–0.887). Elevated liver enzymes were significantly associated with elevated lactate dehydrogenase (aOR, 3.055; 95% CI, 2.257–4.137), presence of pleural effusion (aOR, 2.635; 95% CI, 1.767–3.930), and proteinuria with respiratory virus coinfection (aOR, 2.245; 95% CI, 1.113–4.527). Conclusion: Approximately 24% of pediatric patients with MP had various EPM. As the risk factors associated with each EPM were different, it is necessary to evaluate the various clinical aspects and findings of MP to predict and prepare for the occurrence of EPM.
Abstract
Purpose: Mycoplasma pneumoniae pneumonia (MP) is a major cause of community-acquired pneumonia (CAP) in children and is associated with extrapulmonary manifestations (EPM). The incidence and risk factors for EPM in children are unknown. Methods: This was a retrospective study involving 65,243 pediatric patients with CAP between 2010 and 2015 at 23 nationwide hospitals in South Korea. Medical records were reviewed to collect information regarding the clinical characteristics, radiological results, and laboratory findings. Logistic regression with multivariate analysis was performed to evaluate the risk factors associated with EPM in MP. Results: The incidence of EPM was 23.9%, including elevation of liver enzymes (18.1%), mucocutaneous manifestations (4.4%), proteinuria (4.1%), cardiovascular and neurological manifestations (0.4%), hematologic manifestations (0.2%), and arthritis (0.2%). Statistical analysis showed that mucocutaneous manifestations significantly increased with elevated alanine aminotransferase (adjusted odds ratio [aOR], 3.623; 95% confidence interval [CI], 1.933-6.790) and atopic sensitization (aOR, 2.973; 95% CI, 1.615–5.475) and decreased with respiratory virus coinfection (aOR, 0.273; 95% CI, 0.084–0.887). Elevated liver enzymes were significantly associated with elevated lactate dehydrogenase (aOR, 3.055; 95% CI, 2.257–4.137), presence of pleural effusion (aOR, 2.635; 95% CI, 1.767–3.930), and proteinuria with respiratory virus coinfection (aOR, 2.245; 95% CI, 1.113–4.527). Conclusion: Approximately 24% of pediatric patients with MP had various EPM. As the risk factors associated with each EPM were different, it is necessary to evaluate the various clinical aspects and findings of MP to predict and prepare for the occurrence of EPM.
참고문헌 (25)
- Michelow IC, "Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children", Pediatrics, 113, pp.701~707 (2004)
- Gordon O, "The clinical presentation of pediatric Mycoplasma pneumoniae infections-a single center cohort", Pediatr Infect Dis J, 38, pp.698~705 (2019)
- Lee E, "Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea", BMC Infect Dis, 20, pp.132~ (2020)
- Lee E, "Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance", Respir Med, 175, pp.106209~ (2020)
- 이은, "Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children", Clinical and Experimental Pediatrics, 60(5), pp.151~157 (2017), 대한소아청소년과학회
- Meyer Sauteur PM, "Infection with and carriage of Mycoplasma pneumoniae in children", Front Microbiol, 7, pp.329~ (2016)
- Yamazaki T, "Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae", Front Microbiol, 7, pp.693~ (2016)
- Narita M, "Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis", Front Microbiol, 7, pp.23~ (2016)
- Azumagawa K, "Four cases of arthritis associated with Mycoplasma pneumoniae infection", Pediatr Int, 50, pp.511~513 (2008)
- 송원재, "Pediatric Mycoplasma pneumoniae Infection Presenting with Acute Cholestatic Hepatitis and Other Extrapulmonary Manifestations in the Absence of Pneumonia", Pediatric Gastroenterology, Hepatology & Nutrition, 20(2), pp.124~129 (2017), 대한소아소화기영양학회
- Zhou Y, "More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia", Antimicrob Agents Chemother, 58, pp.1034~1038 (2014)
- 유진호, "마크로라이드 내성 마이코플라즈마 폐렴이 우리에게 안긴 숙제는?", Allergy Asthma & Respiratory Disease, 5(1), pp.1~2 (2017), 대한 소아알레르기 호흡기학회[DOI]
- 위화현, "최근 3번의 대유행 동안 한국 소아에서 발생한마이코플라즈마 폐렴의 임상적 특징", Allergy Asthma & Respiratory Disease, 5(1), pp.8~14 (2017), 대한 소아알레르기 호흡기학회[DOI]
- You-Sook Youn, "Mycoplasma pneumoniae pneumonia in children", Clinical and Experimental Pediatrics, 55(2), pp.42~47 (2012), 대한소아청소년과학회
- Kuo CY, "The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan", J Microbiol Immunol Infect, 55, pp.611~619 (2022)
- Cho YJ, "Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia", PLoS One, 14, pp.e0219463~ (2019)
- Wang Z, "Impact of atopy on the severity and extrapulmonary manifestations of childhood Mycoplasma pneumoniae pneumonia", J Clin Lab Anal, 33, pp.e22887~ (2019)
- Narita M, "Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia", J Infect Chemother, 16, pp.162~169 (2010)
- Annagür A, "Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumonia, Mycoplasma pneumonia and Helicobacter pylori", J Trop Pediatr, 53, pp.313~318 (2007)
- Poddighe D, "Increased total serum immunoglobulin E in children developing Mycoplasma pneumoniae-related extra-pulmonary diseases", Iran J Allergy Asthma Immunol, 17, pp.490~496 (2018)
- Kurata S, "Role of IL-17A and IL-10 in the antigen induced inflammation model by Mycoplasma pneumoniae", BMC Microbiol, 14, pp.156~ (2014)
- Kawai Y, "Extra-pulmonary manifestations associated with Mycoplasma pneumoniae pneumonia in adults", Eur J Int Med, 29, pp.e9~e10 (2016)
- Zhang Y, "The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children", PLoS One, 11, pp.e0156465~ (2016)
- Lu A, "Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children", Respir Care, 60, pp.469~475 (2015)
- De Silva L, "Mycoplasma pneumoniae infection associated C3 glomerulopathy presenting as severe crescentic glomerulonephritis", Case Rep Nephrol, pp.6295543~ (2021)